gpl1 vs tirzepatide The GLP-1 Powerhouses: Semaglutide vs. Explained – Skippack Pharmacy Frontiers | GLP-1/GIP dual agonist

The Summary of Product Characteristics (SmPC) for Wegovy does not list gastric ulcers among known side effects

Conclusion Concerns about a potential pancreatic cancer signal with GLP-1 therapy originated from early reports and limited datasets

In another trial of liraglutide treatment for adolescents aged 1217 years, 88.8% of treated adolescents experienced adverse events, with 64.8% reporting nausea, vomiting, or diarrhea (compared to 36.5% of adolescents in the placebo group, where 84.9% experienced adverse events) (11, 35)

Havent seen any change

Seek emergency care if your symptoms progress or include difficulty breathing